Loading
Takehiko Sawabe

Takehiko Sawabe, MA

Director
Beyond Next Ventures
Takehiko covers Beyond Next Ventures’ investment in biotech start-ups. Prior to Beyond Next Ventures, he was Managing Director in INCJ, where he was involved with investment in biotech start-ups such as Stella Pharma (IPO on TSE Mothers in 2021), Megakaryon, Scohia Pharma etc. He started his career as a medicinal chemist in Meiji Seika in 2000. He was moved to business development in 2006, where he achieved some in-license deals with biotech start-ups. Between Meiji Seika and INCJ, he has career experience in Johnson & Johnson (medical device business development) and AbbVie (Japan portfolio management). He received a Master degree from Graduate School of Pharmaceutical Sciences at the University of Tokyo and a MBA from Graduate School of Management, GLOBIS University.
Speaking In

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS